Hongxiang Chen retweetledi

Today Rahko was acquired by @Odyssey_Tx, a biotech company pioneering next gen immunomodulators and oncology medicine. Our quantum machine learning platform will help advance Odyssey’s mission to enable faster, more efficient drug discovery. Read more: odysseytx.com/news

English



















